Peer-reviewedLicence not stated3 Biotech
Exploring the therapeutic potential of Erycibe paniculata (Roxb.): metabolite profiling and antimalarial, anticancer, and modulation of NF-κB signaling pathway for anti-inflammatory activities
- 1Research Centre of Excellence in Natural Products and Therapeutics, Department of Biotechnology and Bioinformatics, Sambalpur University, Jyoti Vihar, Sambalpur, Odisha India
Related
- Fungal melanin as a bioactive biopolymer: structural diversity, oxidative stress modulation, anticancer mechanisms, and therapeutic perspectives.
- Phase II Metabolite-Inspired Tripeptide Editing Generates Anti-Inflammatory Candidates for Treatment-Refractory Ulcerative Colitis
- Special Issue “Molecular Mechanisms and Therapeutic Targeting of Inflammatory Complications”
- The Molecular Bases of the Interaction between a Saponin from the Roots of Gypsophila paniculata L. and Model Lipid Membranes
- α‐Glucosidase and Acetylcholinesterase (AChE) Inhibitory Activities, Larvicidal Potential and GC–MS Analysis of Endlicheria paniculata: A Combined Experimental and Molecular Docking Study
BibTeX
@article{babu2026exploring,
title = {{Exploring the therapeutic potential of Erycibe paniculata (Roxb.): metabolite profiling and antimalarial, anticancer, and modulation of NF-κB signaling pathway for anti-inflammatory activities}},
author = {Swaraj Kumar Babu and Sk Mustaq Ali and Dibya Ranjan Sahoo and Eeshara Naik and Reshma Pradhan and Satyanshi Behera and Surjeet Verma and Pradeep Kumar Naik},
journal = {3 Biotech},
year = {2026},
month = oct,
doi = {10.1007/s13205-026-05098-y},
url = {https://doi.org/10.1007/s13205-026-05098-y},
}
RIS
TY - JOUR
TI - Exploring the therapeutic potential of Erycibe paniculata (Roxb.): metabolite profiling and antimalarial, anticancer, and modulation of NF-κB signaling pathway for anti-inflammatory activities
AU - Swaraj Kumar Babu
AU - Sk Mustaq Ali
AU - Dibya Ranjan Sahoo
AU - Eeshara Naik
AU - Reshma Pradhan
AU - Satyanshi Behera
AU - Surjeet Verma
AU - Pradeep Kumar Naik
PY - 2026
DA - 2026/10/31
JO - 3 Biotech
DO - 10.1007/s13205-026-05098-y
UR - https://doi.org/10.1007/s13205-026-05098-y
SN - 2190-572X
SN - 2190-5738
ER -